Inventor · disambiguated record
Nilantha Sirisoma
Also filed as: SIRISOMA NILANTHA S · SIRISOMA NILANTHA SUDATH
8 granted patents·12 pending applications·92 citations·filing 2003–2019
85Inventor score
Top patents by PatentIndex Score
20 records- 0192US7618975B24-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofMYRIAD PHARMACEUTICALS INC·Filed 2004·Granted Nov 17, 2009·61 cites·48 claims
- 0281US8258145B2Method of treating brain cancerCAI SUI XIONG·Filed 2007·Granted Sep 4, 2012·9 cites·41 claims
- 0381US7732468B23-aryl-6-aryl-[ 1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2007·Granted Jun 8, 2010·1 cites·4 claims
- 0477US7989462B24-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofMYREXIS INC·Filed 2007·Granted Aug 2, 2011·4 cites·26 claims
- 0574US7176234B2Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Feb 13, 2007·8 cites·45 claims
- 0672US7135480B2Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Nov 14, 2006·6 cites·21 claims
- 0769US7592143B2Methods of treating diseases responsive to induction of apoptosis and screening assaysCYTOVIA INC·Filed 2004·Granted Sep 22, 2009·3 cites·9 claims
- 0861US2008032974A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 0961US2008039479A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 1060US2007249601A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 1160US2007244113A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 1259US2007208044A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 1358US11865110B2Thrombin inhibitors, formulations, and uses thereofVERSEON INT CORPORATION·Filed 2019·Granted Jan 9, 2024·0 cites·20 claims
- 1457US2008045514A13-Aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 1555US2007213305A1N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2006·Application pending·0 cites
- 1655US2017050937A1Compounds and therapeutical use thereofImmune pharmaceuticals inc·Filed 2016·Application pending·0 cites
- 1748US2007099877A1N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2006·Application pending·0 cites
- 1848US2007099941A1N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2006·Application pending·0 cites
- 1946US2007244114A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 2042US2008096848A1Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of ApoptosisCYTOVIA INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →